Silence Therapeutics plc Deferred Tax Expense Income
Silence Therapeutics plc (SLNCF) reported Deferred Tax Expense Income of GBP 0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2024-03-13
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2023-12-31 | 0.00 GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 0.00 GBP 20-F · filed 2023-03-15 |
| 2021-12-31 | 0.00 GBP 20-F · filed 2022-03-17 |